Abstract
This report describes the evaluation of a wide range of structurally diverse “privileged structures”, either amines or acids, linked via urea and amide connections, to the key dipeptide D-Trp-Lys-OMe. This led to the discovery of a collection of potent and structurally distinct SSTR2 ligands in both the amide and urea series. The 4- (benzimidazolone)-piperidine linked SSTR2 agonist (8) is highlighted.
Keywords: peptidyl privileged structures, somatostatin receptor ligands, d-trp-lys-ome, (benzimidazolone)-piperidine
Letters in Drug Design & Discovery
Title: Diverse Peptidyl Privileged Structures as Potent Somatostatin Receptor Ligands
Volume: 1 Issue: 2
Author(s): Alexander Pasternak, Yanping Pan, Ralph T. Mosley, Susan P. Rohrer, Elizabeth T. Birzin, James Schaeffer, Arthur A. Patchett and Lihu Yang
Affiliation:
Keywords: peptidyl privileged structures, somatostatin receptor ligands, d-trp-lys-ome, (benzimidazolone)-piperidine
Abstract: This report describes the evaluation of a wide range of structurally diverse “privileged structures”, either amines or acids, linked via urea and amide connections, to the key dipeptide D-Trp-Lys-OMe. This led to the discovery of a collection of potent and structurally distinct SSTR2 ligands in both the amide and urea series. The 4- (benzimidazolone)-piperidine linked SSTR2 agonist (8) is highlighted.
Export Options
About this article
Cite this article as:
Pasternak Alexander, Pan Yanping, Mosley T. Ralph, Rohrer P. Susan, Birzin T. Elizabeth, Schaeffer James, Patchett A. Arthur and Yang Lihu, Diverse Peptidyl Privileged Structures as Potent Somatostatin Receptor Ligands, Letters in Drug Design & Discovery 2004; 1 (2) . https://dx.doi.org/10.2174/1570180043485563
DOI https://dx.doi.org/10.2174/1570180043485563 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Design and Screening Strategies for α-Glucosidase Inhibitors Based on Enzymological Information
Current Topics in Medicinal Chemistry Synthesis of Purine Derivatives as Scaffolds for a Diversity of Biological Activities
Current Organic Chemistry Potential of Selected Indian Herbs for COVID-19
Current Traditional Medicine A Survey on Protocols Involving QoS in Wireless Sensor Networks
International Journal of Sensors, Wireless Communications and Control A Comprehensive Review on the Medicinal Benefits of Honey with an Emphasis on Unani Medicine
Current Traditional Medicine The Influence of TNF-α, IL-6, TGF-β1, IFN-γ, IL-10 Polymorphisms on Predisposition to Diabetes Mellitus among Jordanian Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Exploring the Recent Trends in Management of Dementia and Frailty: Focus on Diagnosis and Treatment
Current Medicinal Chemistry Synthesis, Bioactivities and In-silico Docking Studies of Azaleatin-A Quercetin Partial Methyl Ether: SAR Study
Current Bioactive Compounds Synthesis of a 2, 4, 8-Trisubstituted Pyrimidino[5, 4-d]Pyrimidine Library via Sequential SNAr Reactions on Solid-Phase
Combinatorial Chemistry & High Throughput Screening Subversion of the Oral Microbiota and Induction of Immune-Mediated Systemic Inflammation with Special Reference to Periodontitis: Current Knowledge and Perspectives
Endocrine, Metabolic & Immune Disorders - Drug Targets Design of Ester Prodrugs to Enhance Oral Absorption of Poorly Permeable Compounds: Challenges to the Discovery Scientist
Current Drug Metabolism A Concept of Homeostatic Inflammation Provided by Endogenous TLR4 Agonists that Function Before and After Danger Signal for Metastasis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Strategies and Methods for the Synthesis of Anticancer Natural Product Neopeltolide and its Analogs
Current Organic Chemistry Why is Glycine not a Part of the Osmoticum in the Urea-rich Cells?
Protein & Peptide Letters Phomoxanthone A - From Mangrove Forests to Anticancer Therapy
Current Medicinal Chemistry Forging New Scaffolds from Old: Combining Scaffold Hopping and Hierarchical Virtual Screening for Identifying Novel Bcl-2 Inhibitors
Current Topics in Medicinal Chemistry Medicinal Attributes of Heterocyclic Compounds in Rheumatoid Arthritis: Recent Developments and SAR Studies
Current Topics in Medicinal Chemistry Structure-Based Quantitative Structure Activity Relationship Analysis of Omuralide Analogs in the 20S Proteasome: A Covalent Inhibitor COMBINE Study
Letters in Drug Design & Discovery Diagnostics, Prognostic and Therapeutic Exploitation of Telomeres and Telomerase in Leukemias
Current Pharmaceutical Biotechnology Acknowledgement to Reviewers
Current Traditional Medicine